ConductScience.org, home

Paper42272829

Multi-target mechanisms and therapeutic potential of Dahuang Zhechong pill in lower extremity peripheral artery disease: a structured narrative review.

Teng Y and 3 others. Front Pharmacol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Multi-target mechanisms and therapeutic potential of Dahuang Zhechong pill in lower extremity peripheral artery disease: a structured narrative review. Papers, record 42272829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42272829

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Multi-target mechanisms and therapeutic potential of Dahuang Zhechong pill in lower extremity peripheral artery disease: a structured narrative review.
PubMed
Journal
Front Pharmacol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Teng YYue
2Zhang YYouzhi
3Lv BBochuan
4Xu JJintao

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References91

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133935784Pharmacological Activities and Mechanisms of Hirudin and Its Derivatives - A Review.Front Pharmacol2021https://conductscience.org/library/papers/33935784PubMed
234788653A meta-analysis of randomized controlled trials on therapeutic efficacy and safety of autologous cell therapy for atherosclerosis obliterans.J Vasc Surg2022https://conductscience.org/library/papers/34788653PubMed
38638868Plasma viscosity increase with progression of peripheral arterial atherosclerotic disease.Angiology1996https://conductscience.org/library/papers/8638868PubMed
412243231Anticoagulant activities in salivary glands of tabanid flies.Med Vet Entomol2002https://conductscience.org/library/papers/12243231PubMed
535700853Scoping review of the medicinal effects of Eupolyphaga sinensis Walker and the underlying mechanisms.J Ethnopharmacol2022https://conductscience.org/library/papers/35700853PubMed
622218934Potential anti-inflammatory, anti-adhesive, anti/estrogenic, and angiotensin-converting enzyme inhibitory activities of anthocyanins and their gut metabolites.Genes Nutr2012https://conductscience.org/library/papers/22218934PubMed
739701744[Clinical comprehensive evaluation of Jiangzhi Tongluo Soft Capsules for treating hyperlipidemia (syndrome of blood stasis and Qi stagnation)].Zhongguo Zhong Yao Za Zhi2024https://conductscience.org/library/papers/39701744PubMed
838694094Protective effects of the bioactive peptide from maggots against skin flap ischemia‒reperfusion injury in rats.Heliyon2024https://conductscience.org/library/papers/38694094PubMed
930759852Apricot Kernel Extract and Amygdalin Inhibit Urban Particulate Matter-Induced Keratoconjunctivitis Sicca.Molecules2019https://conductscience.org/library/papers/30759852PubMed
1034502424The Health Benefits of Emodin, a Natural Anthraquinone Derived from Rhubarb-A Summary Update.Int J Mol Sci2021https://conductscience.org/library/papers/34502424PubMed
1138931317The Effects of Almond Consumption on Cardiovascular Health and Gut Microbiome: A Comprehensive Review.Nutrients2024https://conductscience.org/library/papers/38931317PubMed
1232924559Traditional Chinese Medicine Could Play an Important Role in Integrative Palliative Care in China.J Altern Complement Med2020https://conductscience.org/library/papers/32924559PubMed
1339528464Inflammation in atherosclerosis: pathophysiology and mechanisms.Cell Death Dis2024https://conductscience.org/library/papers/39528464PubMed
1429952767Platelet-RBC interaction mediated by FasL/FasR induces procoagulant activity important for thrombosis.J Clin Invest2018https://conductscience.org/library/papers/29952767PubMed
1539355399Nrf2 Connects Cellular Autophagy and Vascular Senescence in Atherosclerosis: A Mini-Review.J Lipid Atheroscler2024https://conductscience.org/library/papers/39355399PubMed
1629950086[Species and medical history of "Xishuang" medicinal materials].Zhongguo Zhong Yao Za Zhi2018https://conductscience.org/library/papers/29950086PubMed
1732692190Herbal therapy treatment in thromboangiitis obliterans: a retrospective clinical study.Ann Palliat Med2020https://conductscience.org/library/papers/32692190PubMed
1837381959[Effect and mechanism of Dahuang Zhechong Pills in improving liver aging in rats by regulating ROS-mediated PI3K/Akt/FoxO4 signaling pathway].Zhongguo Zhong Yao Za Zhi2023https://conductscience.org/library/papers/37381959PubMed
1940666694Exploring the Complementary Role of Traditional Chinese Medicine in Enhancing Percutaneous Coronary Intervention Outcomes: Mechanisms, Benefits, and Future Research Directions.Ther Clin Risk Manag2025https://conductscience.org/library/papers/40666694PubMed
2038888716Dahuang Zhechong Pill Alleviates Liver Fibrosis Progression by Regulating p38 MAPK/NF-κ B/TGF-β1 Pathway.Chin J Integr Med2024https://conductscience.org/library/papers/38888716PubMed

See all 91 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42272829

GET https://conductscience.org/api/papers/v1/42272829/references?page=2